• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC SMARTABLATE¿ SYSTEM RF GENERATOR (US); CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC SMARTABLATE¿ SYSTEM RF GENERATOR (US); CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number M490007
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fistula (1862); No Code Available (3191)
Event Date 11/13/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).The hardware investigation has begun but it has not been completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.Still pending is the manufactured date.Therefore, a supplemental report will be submitted.Biosense webster manufacturer's reference number (b)(4) has two complaints that are related to the same incident.Manufacturer's reference # (b)(4).
 
Event Description
It was reported that a (b)(6)-year-old male patient underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch¿ bi-directional navigation catheter and a smartablate¿ system rf generator (us) and suffered atrioesophageal fistula requiring surgical intervention.Post procedure and post use of biosense webster, inc.Products, the patient complained of having sub-sternal chest pain.The patient was referred for a chest computed tomography (ct) scan.The scan showed the patient had developed an esophageal fistula and two holes were found below the right pulmonary vein in the left atrium.The patient was taken to another hospital and underwent surgery to repair the esophageal fistula.The physician noted that the patient was in stable condition.The physician¿s opinion on the cause of the adverse event is unknown, however, the physician did not implicate anyone or anything to be the cause.Extended hospitalization was required because the esophageal fistula repair was not successful.At the time of the report, it was noted that the patient was still in the hospital.The outcome of the adverse event is unchanged.There were no error messages displayed on any biosense webster, inc.Equipment.The generator was operating with 50 watts of power, average contact force of 23 g for 34 seconds, average temperature of 23 degrees celsius and impedance of 16 ohm.The modality used to prevent the esophageal fistula was the esophageal temperature probe.The carto® 3 system did not indicate to re-zero the catheter.The force visualization features that were used were graph, dashboard, vector and visitag.The parameters for stability were 2.5mm/3sec.Additional filter that was used was surpoint module and the color options that were used prospectively was surpoint tag index.
 
Manufacturer Narrative
Investigation summary- it was reported that a 36-year-old male patient underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch¿ bi-directional navigation catheter and a smartablate¿ system rf generator (us) and suffered atrioesophageal fistula requiring surgical intervention.Post procedure and post use of biosense webster, inc.Products, the patient complained of having sub-sternal chest pain.The patient was referred for a chest computed tomography (ct) scan.The scan showed the patient had developed an esophageal fistula and two holes were found below the right pulmonary vein in the left atrium.The patient was taken to another hospital and underwent surgery to repair the esophageal fistula.The physician noted that the patient was in stable condition.The physician¿s opinion on the cause of the adverse event is unknown, however, the physician did not implicate anyone or anything to be the cause.The device was evaluated, and the secure digital (sd) card was found to be defective.The secure digital (sd) card was reprogrammed, and the issue was resolved.The smartablate¿ system rf generator (us) was also subjected to preventative maintenance (pm), safety and functional testing and all tests passed.The customer complaint was not confirmed for the adverse event.It was confirmed that the secure digital (sd) card was defective, however, the defective secure digital (sd) card could not contribute the adverse event.A manufacturing record evaluation was performed for the finished device and no internal actions related to the reported complaint condition were identified.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Biosense webster manufacturer's reference number (b)(4) has two complaints that are related to the same incident.Manufacturer's reference # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMARTABLATE¿ SYSTEM RF GENERATOR (US)
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
33 technology drive
irvine CA 92618
MDR Report Key9419617
MDR Text Key180631443
Report Number2029046-2019-03958
Device Sequence Number1
Product Code LPB
UDI-Device Identifier04260166371390
UDI-Public04260166371390
Combination Product (y/n)N
PMA/PMN Number
P990071/S017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 11/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/05/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM490007
Device Catalogue NumberM490007
Date Manufacturer Received01/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CARTO 3 SYSTEM; THMCL SMRTTCH,BI,NAV,TC,F-J,C3
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age36 YR
-
-